CORMORANT ASSET MANAGEMENT, LP – Edgewise Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$30.03M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+23.62%
quarter
Edgewise Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -20.73% | -798.01K shares | -614K | $9.84 | 3.05M |
| Q2 2022 | share | Decrease | -17.79% | -832.87K shares | -14.77M | $7.96 | 3.85M |
| Q1 2022 | share | Increase | +31.32% | 1.11M shares | -9.06M | $9.7 | 4.68M |
| Q4 2021 | share | Increase | +5.78% | 194.98K shares | -1.47M | $14.81 | 3.56M |
| Q3 2021 | share | Increase | +7.32% | 230K shares | -10.57M | $16.6 | 3.37M |
| Q2 2021 | share | Increase | +34.17% | 800K shares | -7.77M | $21.33 | 3.14M |
| Q1 2021 | share | Increase | 0.00% | 2.34M shares | 74.30M | $32.5 | 2.34M |